Measurement of Insulin Levels in the Cerebrospinal Fluid of Healthy Adults After a Single Intranasal Dose - Middle Age

NCT06434038 · clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped We are closing this clinical protocol due to supply chain issues. We are no longer able to obtain the intranasal delivery device.

Conditions

Interventions

Sponsor

HealthPartners Institute

Collaborators